Institution: | 1.Health Economics Department, Janssen Pharmaceutical K.K., Tokyo, Japan ;2.Immunology, Infectious Diseases and Vaccine Department, Medical Affairs Division, Janssen Pharmaceutical K.K., Tokyo, Japan ;3.Real World Evidence Consultant, Parexel International, Stockholm, Sweden ; |